Εμφάνιση απλής εγγραφής

dc.creatorRoumeliotis A., Roumeliotis S., Leivaditis K., Salmas M., Eleftheriadis T., Liakopoulos V.en
dc.date.accessioned2023-01-31T09:51:56Z
dc.date.available2023-01-31T09:51:56Z
dc.date.issued2021
dc.identifier10.1007/s11255-020-02678-6
dc.identifier.issn03011623
dc.identifier.urihttp://hdl.handle.net/11615/78571
dc.description.abstractThe use of Automated Peritoneal Dialysis (APD) in its various forms has increased over the past few years mainly in developed countries. This could be attributed to improved cycler design, apparent lifestyle benefits and the ability to achieve adequacy and ultrafiltration targets. However, the dilemma of choosing the superior modality between APD and Continuous Ambulatory Peritoneal Dialysis (CAPD) has not yet been resolved. When it comes to fast transporters and assisted PD, APD is certainly considered the most suitable Peritoneal Dialysis (PD) modality. Improved patients’ compliance, lower intraperitoneal pressure and possibly lower incidence of peritonitis have been also associated with APD. However, concerns regarding increased cost, a more rapid decline in residual renal function, inadequate sodium removal and disturbed sleep are APD’s setbacks. Besides APD superiority over CAPD in fast transporters, the other medical advantages of APD still remain controversial. In any case, APD should be readily available for all patients starting PD and the most important indication for its implementation remains patient’s choice. © 2020, Springer Nature B.V.en
dc.language.isoenen
dc.sourceInternational Urology and Nephrologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85092466971&doi=10.1007%2fs11255-020-02678-6&partnerID=40&md5=8799d14466fe40e85af075ee7e71cb7d
dc.subjectglucoseen
dc.subjectautomated peritoneal dialysisen
dc.subjectblood pressureen
dc.subjectcontinuous ambulatory peritoneal dialysisen
dc.subjectcoronavirus disease 2019en
dc.subjectemploymenten
dc.subjectend stage renal diseaseen
dc.subjectfinancial managementen
dc.subjectglucose blood levelen
dc.subjecthealth care costen
dc.subjectheart left ventricle hypertrophyen
dc.subjecthumanen
dc.subjectincidenceen
dc.subjectkidney functionen
dc.subjectlifestyle modificationen
dc.subjectnatural disasteren
dc.subjectpandemicen
dc.subjectpatient complianceen
dc.subjectpatient preferenceen
dc.subjectperitoneal dialysisen
dc.subjectperitonitisen
dc.subjectquality of lifeen
dc.subjectReviewen
dc.subjectsleep disorderen
dc.subjectsurvival rateen
dc.subjectultrafiltrationen
dc.subjectchronic kidney failureen
dc.subjectcontinuous ambulatory peritoneal dialysisen
dc.subjectpatient selectionen
dc.subjectHumansen
dc.subjectKidney Failure, Chronicen
dc.subjectPatient Selectionen
dc.subjectPeritoneal Dialysisen
dc.subjectPeritoneal Dialysis, Continuous Ambulatoryen
dc.subjectSpringer Science and Business Media B.V.en
dc.titleAPD or CAPD: one glove does not fit allen
dc.typeotheren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής